Carol Houts steps into the role of CEO at Germfree with nearly three decades of experience spanning pharmaceutical and biologics product development, quality, regulatory affairs, and clinical research, and a proven record of driving Germfree’s commercial and strategic growth from within.
Before assuming the CEO role, Carol served as Germfree’s Chief Commercial Officer and also as the Chief Strategy Officer, where she played a central role in shaping the company’s direction, expanding its market presence, and positioning Germfree as the leading provider of innovative offsite cleanroom and facility solutions for biopharmaceutical applications.
Carol’s career prior to Germfree spans executive leadership at full-service clinical research organizations including QST Consultations, Clinartis, BioRASI, and Pleiad (Cromsource), where she led global operations across clinical, regulatory, and pharmacovigilance functions. She has also held quality and compliance roles at Pfizer, Stryker Biotech, and Biomimetic Therapeutics, a foundation that informs both her scientific rigor and her business instincts.

